Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LRCH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MAP2K7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MZT2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SYPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZKSCAN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORMDL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD10-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
UBE2L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POU2F1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCGR1CP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GABRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00358 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLJ30064 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IVD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFA13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WRNIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on